Rating History for Amylin Pharmaceuticals (AMLN) by Morgan Stanley

More Stocks Rated by Morgan Stanley | Latest Ratings for AMLN
Date Type Rating
(Past)		 PT
(Past)		 Start $ End $ % Chg. Details
7/3/2012 Upgrade Equalweight
(Underweight)		 N/A
(N/A)		 30.71 30.98 0.88% Details
9/8/2010 New Coverage Underweight
(N/A)		 N/A
(N/A)		 21.52 30.71 42.7% Details